Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ABCC1 overexpression
Cancer:
Hepatocellular Cancer
Drug Class:
Immunotherapy
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Source:
Eur Rev Med Pharmacol Sci
Title:
ABCC1 is a predictive biomarker for prognosis and therapy in hepatocellular carcinoma
Excerpt:
This indicated that patients with a high expression of ABCC1 might respond poorly to immune checkpoint blockade (ICB) therapy (p = 9.2e-07).
DOI:
10.26355/eurrev_202304_32143
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login